XXI Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
XXI Wealth's BMY Position: Q3 2026 in Review
XXI Wealth increased its Bristol-Myers Squibb (BMY) stake by 87% in Q3 2026, buying an estimated $887K and bringing the position to 30,096 shares worth $1.88M. The position accounts for 0.75% of the portfolio, ranked #29.
XXI Wealth first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 2,283 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- XXI Wealth held 30,096 shares of Bristol-Myers Squibb worth $1.88M as of Q3 2026.
- XXI Wealth bought 14,039 Bristol-Myers Squibb shares in Q3 2026, an estimated $887K.
- Bristol-Myers Squibb made up 0.75% of XXI Wealth's portfolio in Q3 2026, its #29 holding.
- XXI Wealth first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
- 2,283 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.